BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15223904)

  • 1. Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation.
    Steinhauff S; Pehlivanli S; Bakovic-Alt R; Meiser BM; Becker BF; von Scheidt W; Weis M
    Transplantation; 2004 Jun; 77(12):1859-65. PubMed ID: 15223904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.
    Benacerraf S; Carville C; Adnot S; Montagne O; Sediame S; Belhassen L; Dubois-Randé JL
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):368-73. PubMed ID: 10470994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
    Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
    J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
    Hornig B; Arakawa N; Haussmann D; Drexler H
    Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
    Schneider CA; Voth E; Moka D; Baer FM; Melin J; Bol A; Wagner R; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1999 Oct; 34(4):1005-11. PubMed ID: 10520782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Fraunberger P; Meiser BM; von Scheidt W
    Transplantation; 1999 Nov; 68(9):1263-7. PubMed ID: 10573061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart allograft endothelial cell dysfunction. Cause, course, and consequences.
    Weis M; Pehlivanli S; von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/58-62. PubMed ID: 11151795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin in coronary endothelial dysfunction early after human heart transplantation.
    Weis M; Wildhirt SM; Schulze C; Rieder G; Wilbert-Lampen U; Wolf WP; Arendt RM; Enders G; Meiser BM; von Scheidt W
    J Heart Lung Transplant; 1999 Nov; 18(11):1071-9. PubMed ID: 10598730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation.
    Kugiyama K; Ohgushi M; Motoyama T; Hirashima O; Soejima H; Misumi K; Yoshimura M; Ogawa H; Sugiyama S; Yasue H
    Circulation; 1998 Jun; 97(23):2299-301. PubMed ID: 9639372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone.
    MacCarthy PA; Pegge NC; Prendergast BD; Shah AM; Groves PH
    J Am Coll Cardiol; 2001 Jan; 37(1):137-43. PubMed ID: 11153728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic stimulation overrides flow-mediated endothelium-dependent epicardial coronary vasodilation in transplant patients.
    Aptecar E; Dupouy P; Benvenuti C; Mazzucotelli JP; Teiger E; Geschwind H; Castaigne A; Loisance D; Dubois-Rande JL
    Circulation; 1996 Nov; 94(10):2542-50. PubMed ID: 8921799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans.
    Takano H; Kodama Y; Kitta Y; Nakamura T; Obata JE; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Hasebe H; Kugiyama K
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2641-6. PubMed ID: 16877558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator response to nifedipine in human coronary arteries with endothelial dysfunction.
    Weis M; Pehlivanli S; von Scheidt W
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):172-80. PubMed ID: 11791002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations of segmental endothelium-dependent and endothelium-independent vasomotor tone after cardiac transplantation (qualitative changes in endothelial function).
    Weis M; Peter-Wolf W; Mazzilli N; Olbrich HG; Schacherer C; Wiemer J; Burger W; Hartmann A
    Am Heart J; 1997 Aug; 134(2 Pt 1):306-15. PubMed ID: 9313612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
    Prasad A; Husain S; Quyyumi AA
    J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent microvascular vasomotion and its correlation with vasoactive mediators early after cardiac transplantation in humans.
    Wildhirt SM; Weis M; Schulze C; Rieder G; Enders G; Wilbert-Lampen U; Ueberfuhr P; Reichenspurner H; von Scheidt W; Reichart B
    Transpl Int; 1998; 11 Suppl 1():S519-24. PubMed ID: 9665050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.